Treatment with Brilinta 60mg, either as continuation therapy after the initial 12 month post-event period, or with as limited interruption as possible, is associated with a clear and favourable ...

It is the first prospective trial to evaluate longer term dual antiplatelet therapy in higher risk patients with a history of a heart attack, according to AZ. Brilinta is one of six growth ...